Answers are grounded in this paper and cite their sources.
Clinical evaluation demonstrates immediate hemostasis in gastrointestinal bleeding using modified autogenous clots, indicating effective embolization alongside potential ischemic risks.
Clinical and laboratory experience with clot additives and with the use of modified autogenous clot as an agent for transcatheter hemostasis is described. Oxycel (oxidized cellulose) produces a highly occlusive, relatively stable, firm clot and is eventually absorbed. It offers a firm matrix for clot formation, promotes coagulation despite a variety of deficient clotting factors, increases clot durability, and delays clot lysis. All nine patients in the clinical study showed immediate cessation of gastrointestinal bleeding. Two instances of transient duodenal infarction, attributable to the use of clots, indicate that the method is not without some risk.
No takes yet. Share an insight, caveat, or question.
Bookstein et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: